Academic Journal

Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy.
Συγγραφείς: Chida K; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Oura A; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Takahashi T; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Kiyohara M; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Matsumoto K; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Kyo T; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Ishizuka Y; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Kamei H; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Nakamura Y; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan., Nakaya I; Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Japan.
Πηγή: Internal medicine (Tokyo, Japan) [Intern Med] 2026 Jun 15; Vol. 65 (12), pp. 1650-1656. Date of Electronic Publication: 2025 Nov 06.
Τύπος έκδοσης: Journal Article; Case Reports
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE
Imprint Name(s): Original Publication: Tokyo, Japan : Japanese Society of Internal Medicine, [1992-
Ιατρικοί όροι (MeSH): Immunosuppressive Agents*/therapeutic use , Glomerulonephritis, Membranoproliferative*/drug therapy , Glomerulonephritis, Membranoproliferative*/immunology , Immunoglobulin A* , Immunoglobulin lambda-Chains*, Mycophenolic Acid/therapeutic use ; Cyclophosphamide/therapeutic use ; Humans ; Male ; Middle Aged ; Remission Induction ; Recurrence
Περίληψη: A 58-year-old man was admitted to our hospital in April 2013 with elevated serum creatinine levels, proteinuria, and hematuria. A renal biopsy revealed membranoproliferative glomerulonephritis-like changes. Immunofluorescence showed IgA1 and λ light chain deposits along the capillary walls, confirming IgA-λ type proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID). Complete remission was achieved with glucocorticoid monotherapy in December 2013. After a relapse in April 2021, immunosuppressive treatment, including intravenous cyclophosphamide and subsequent mycophenolate mofetil, led to a complete remission. This case indicates that conventional immunosuppressive therapy may be effective for IgA-type PGNMID.
Contributed Indexing: Keywords: IgA-type PGNMID; clone-directed therapy; immunosuppressive therapy; monoclonal gammopathy of renal significance; proliferative glomerulonephritis with monoclonal immunoglobulin deposits
Substance Nomenclature: 0 (Immunosuppressive Agents)
0 (Immunoglobulin A)
HU9DX48N0T (Mycophenolic Acid)
0 (Immunoglobulin lambda-Chains)
8N3DW7272P (Cyclophosphamide)
Entry Date(s): Date Created: 20251105 Date Completed: 20260614 Latest Revision: 20260726
Update Code: 20260726
PubMed Central ID: PMC13349478
DOI: 10.2169/internalmedicine.6357-25
PMID: 41192914
Βάση Δεδομένων: MEDLINE